BIOLASE, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2012-12-06: Form 8-K; Period of report 2012-12-06; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2012-12-04: Form 8-K; Period of report 2012-12-04; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2012-11-05: Form 8-K; Period of report 2012-11-05; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2012-10-09: Form 8-K; Period of report 2012-10-04; Description 7.01 Regulation FD Disclosure; Details 7.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2012-12-06 | 8-K | 2012-12-06 | 7.01 Regulation FD Disclosure | 7.01 On December 6, 2012, Frederick Furry, Chief Operating Officer and Chief Financial Officer of Biolase, Inc. (the “Company”) will deliver a presentation at the Fifth Annual LD Micro Conference that will include a written communication comprised of slides. | d449210d8k.htm |
| 2012-12-04 | 8-K | 2012-12-04 | 7.01 Regulation FD Disclosure | 7.01 On December 4, 2012, Frederick Furry, Chief Operating Officer and Chief Financial Officer of Biolase, Inc. (the “Company”) will deliver a presentation at the Canaccord Genuity 2012 Medical Technology & Diagnostics Forum that will include a written communication comprised of slides. | d449212d8k.htm |
| 2012-11-05 | 8-K | 2012-11-05 | 2.02 Results of Operations and Financial Condition | 2.02 On November 5, 2012, Biolase, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2012. | htm_46367.htm |
| 2012-10-09 | 8-K | 2012-10-04 | 7.01 Regulation FD Disclosure | 7.01 On October 4, 2012, Frederick Furry, Chief Operating Officer and Chief Financial Officer of Biolase, Inc. (the “Company”) delivered a presentation at the LD Micro Summit that included a written communication comprised of slides. | d421468d8k.htm |
| 2012-09-12 | 8-K | 2012-09-11 | 7.01 Regulation FD Disclosure | 7.01 On September 11, 2012, Federico Pignatelli, Chairman and Chief Executive Officer of Biolase, Inc. (the “Company”) delivered a presentation at the Rodman & Renshaw Annual Global Investment Conference that included a written communication comprised of slides. | d411249d8k.htm |
| 2012-08-08 | 8-K | 2012-08-08 | 2.02 Results of Operations and Financial Condition | 2.02 On August 8, 2012, Biolase, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2012. | htm_45768.htm |
| 2012-05-30 | 8-K | 2012-05-24 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 2.03 On May 24, 2012, the Company entered into a Loan and Security Agreement (the "Loan and Security Agreement") in respect of a $4 million revolving credit facility (the "Domestic Revolver") and a Borrower Agreement (the "Borrower Agreement," and together with the Loan and Security Agreement, the "Loan Agreements") under the Export-Import Bank of the United States Working Capital Guarantee Program in respect of a $4 million revolving credit facility (the "Ex-Im Revolver") with Comerica Bank (the "Lender") for credit facility funding of up to an aggregate amount of $8 million. 8.01 On May 29, 2012, the Company issued a press release announcing the credit facilities disclosed in Item 2.03 above. | htm_45248.htm |
| 2012-05-23 | 8-K | 2012-05-23 | 7.01 Regulation FD Disclosure | 7.01 On May 23, 2012, Frederick Furry, Chief Operating Officer and Chief Financial Officer of Biolase Technology, Inc. (the “Company”) will deliver a presentation at the 13th Annual B. Riley & Co. Investor Conference that will include a written communication comprised of slides. | d357615d8k.htm |
| 2012-05-16 | 8-K | 2012-05-10 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders; 7.01 Regulation FD Disclosure | 5.03 On May 10, 2012, Biolase Technology, Inc. (the "Company") held its 2012 Annual Meeting of Stockholders (the Annual Meeting"). 7.01 On May 10, 2012, the Board of Directors of the Company declared a one-half percent stock dividend. | htm_45089.htm |
| 2012-05-09 | 8-K | 2012-05-09 | 2.02 Results of Operations and Financial Condition | 2.02 On May 9, 2012, Biolase Technology, Inc. issued a press release announcing its financial results for the first quarter ended March 31, 2012. | htm_45010.htm |
| 2012-04-30 | 8-K | 2012-04-24 | 8.01 Other Events | 8.01 On April 24, 2012, Biolase Technology, Inc. (the "Company") received notice that CAO Group, Inc. ("CAO") has filed a lawsuit against the Company in the United States District Court for the District of Utah. | htm_44894.htm |
| 2012-04-16 | 8-K | 2012-04-16 | 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure | 2.02 On April 16, 2012, Biolase Technology, Inc. (the "Company") issued a press release announcing preliminary financial results for the first quarter ended March 31, 2012. 7.01 A copy of the Company's press release is filed as Exhibit 99.2 to this Current Report on Form 8-K, and is incorporated by reference herein. | htm_44733.htm |
| 2012-04-04 | 8-K | 2012-04-04 | 7.01 Regulation FD Disclosure | 7.01 On April 4, 2012, Frederick Furry, Chief Operating Officer and Chief Financial Officer of Biolase Technology, Inc. (the “Company”) will deliver a presentation at the 11th Annual Needham Healthcare Conference that will include a written communication comprised of slides. | d329291d8k.htm |
| 2012-03-09 | 8-K | 2012-03-08 | 2.02 Results of Operations and Financial Condition | 2.02 On March 8, 2012, Biolase Technology, Inc. (the "Company") issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2011. | htm_44475.htm |
| 2012-02-28 | 8-K | 2012-02-22 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.02 Results of Operations and Financial Condition | 1.01 Entry into a Material Definitive Agreement. 1.02 The information set forth in Item 1.01 of this Current Report on Form 8-K relating to the termination of the Distribution Agreement and the termination of the Security Agreement is hereby incorporated by reference in this Item 1.02. 2.02 On February 28, 2012, the Company issued a press release announcing preliminary revenue figures for the fourth quarter and year ended December 31, 2011. | htm_44378.htm |
| 2012-02-14 | 8-K | 2012-02-12 | 7.01 Regulation FD Disclosure | 7.01 On February 12, 2012, Federico Pignatelli, Chairman and Chief Executive Officer of Biolase Technology, Inc. (the “Company”), delivered a presentation at the World Money Show in Orlando, Florida that included a written communication comprised of slides. | d301871d8k.htm |